Clinical Korean Medicine, Graduate School, Kyung Hee University, Seoul, Republic of Korea.
Department of Acupuncture & Moxibustion, National Medical Center, Seoul, Republic of Korea.
BMJ Open. 2021 Dec 9;11(12):e051880. doi: 10.1136/bmjopen-2021-051880.
Patients with HIV/AIDS have been able to experience the average life expectancy of the general population due to medical advancements. However, they face physical, emotional and social difficulties that worsen their quality of life. The pharmacological approach is often the first choice to address these issues, but it involves some limitations. Integrative traditional East Asian medicine (ITEAM) can compensate for the limitations of drugs and can be applied to treat physiological and psychiatric problems. In Korea, ITEAM interventions are easily accessible under the government insurance. However, the experiences, perceptions and barriers to the use of ITEAM in patients with HIV/AIDS are less studied. Therefore, we will interview them to explore their experiences and examine the strengths, limitations, barriers and improvements in the use of ITEAM.
This is a qualitative study using a phenomenological framework. We will conduct one-to-one interviews with 3-10 patients with HIV/AIDS who have been treated with ITEAM from March 2021 to January 2022. We will present semistructured open-ended questions and analyse them using experiential phenomenological research methods. The results will be reported in accordance with the Consolidated Criteria for Reporting Qualitative Studies.
This research was approved by the Institutional Review Board of the National Medical Center (IRB number, NMC-2101-008). The results of this study will be disseminated through journal articles, newspapers and conference proceedings.
Clinical Research Information Service: KCT0005855; Pre-results.
由于医疗技术的进步,HIV/AIDS 患者能够达到普通人群的平均预期寿命。然而,他们面临着身体、情感和社会方面的困难,这些困难使他们的生活质量恶化。药物治疗通常是解决这些问题的首选方法,但它存在一些局限性。整合式传统东亚医学(ITEAM)可以弥补药物的局限性,并且可以应用于治疗生理和心理问题。在韩国,ITEAM 干预措施可以在政府保险下轻松获得。然而,HIV/AIDS 患者对 ITEAM 的使用经验、看法和障碍研究较少。因此,我们将对他们进行访谈,以探讨他们的经验,并检查 ITEAM 的优势、局限性、障碍和改进。
这是一项使用现象学框架的定性研究。我们将在 2021 年 3 月至 2022 年 1 月期间,对接受 ITEAM 治疗的 3-10 名 HIV/AIDS 患者进行一对一访谈。我们将提出半结构化的开放式问题,并使用体验现象学研究方法进行分析。结果将按照《定性研究报告的统一标准》进行报告。
本研究已获得国立医疗中心机构审查委员会的批准(IRB 编号:NMC-2101-008)。本研究的结果将通过期刊文章、报纸和会议论文进行传播。
临床研究信息服务:KCT0005855;预结果。